Levocetirizine Dihydrochloride Tablet, Coated
Product Images NDC 11673-847

2 FDA label images from Target Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 11673-847). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Target Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Target Levo 35ct Carton)

Carton (Target Levo 35ct Carton)
Packaging label for up&up Allergy Relief levocetirizine dihydrochloride tablets USP 5 mg, coated oral tablets. The label shows original prescription strength with 35 tablets per bottle. The product is labeled as an antihistamine providing 24-hour relief for allergy symptoms. Labeler is Target Corporation, Minneapolis, MN.*
FDA Label Image

Container (Target Levo 35ct Label)

Container (Target Levo 35ct Label)
Drug Facts label for levocetirizine dihydrochloride 5 mg coated tablets, an antihistamine marketed under the brand Allergy Relief by Target Corporation. The label includes active ingredient, uses, warnings, directions for adults and children, storage information, inactive ingredients, and a consumer contact number. It specifies dosage limits, contraindications, and precautions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.